163 related articles for article (PubMed ID: 6425226)
1. 99mTc-labelled compounds prepared with molybdenum III as reducing agent.
Vilcek S; Machán V; Kalincák M
Int J Appl Radiat Isot; 1984 Mar; 35(3):228-30. PubMed ID: 6425226
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
Vilcek S; Kalincák M; Machán V
Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-labelled compounds prepared with antimony(III) as reducing agent.
Vilcek S; Machán V; Kalincák M
Radiobiol Radiother (Berl); 1983; 24(1):103-8. PubMed ID: 6407061
[No Abstract] [Full Text] [Related]
4. 99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agent.
Agha NH; Al-Hilli AM; Hassen HA
Nuklearmedizin; 1981 Dec; 20(6):299-304. PubMed ID: 6799937
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and radiolabeling of a new amphiphilic derivative of DTPA.
Aldenhoff YB; Van Kroonenburgh MJ; Koole LH
Nucl Med Biol; 1996 Jul; 23(5):653-6. PubMed ID: 9044688
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-labelled compounds prepared with antimony (III) as reducing agent.
Vilcek S; Machán V; Kalincák M
Radiobiol Radiother (Berl); 1982; 23(3):333-8. PubMed ID: 6758027
[No Abstract] [Full Text] [Related]
7. Reaction of 99mTc-diphosphonate with N-donor ligands.
Johannsen B
Int J Appl Radiat Isot; 1982 Jun; 33(6):429-32. PubMed ID: 6286510
[No Abstract] [Full Text] [Related]
8. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
Djokić DDj; Janković DLj; Stamenković LLj; Pirmettis I
Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303
[TBL] [Abstract][Full Text] [Related]
9. Preparation and quality control of 99mTc-calciumgluconate.
Zmbova B; Djokić D; Jovanović V; Tadzer I; Memedović T
Nuklearmedizin; 1983 Jun; 22(3):166-8. PubMed ID: 6622264
[TBL] [Abstract][Full Text] [Related]
10. 99mTc(Cu)-mannitol complex: a new agent for dynamic renal function studies.
Chauhan UP; Chander J; Mishra P; Sarin RC; Narayanan RV; Singh B
Int J Rad Appl Instrum B; 1989; 16(3):283-9. PubMed ID: 2497090
[TBL] [Abstract][Full Text] [Related]
11. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
[TBL] [Abstract][Full Text] [Related]
12. Technetium-1,2-dihydroxy-1,2-bis(dihydroxyphosphinyl)ethane (99mTc-DHPE). A promising new skeletal imaging agent.
Archimandritis SC; Tsolis AK
Eur J Nucl Med; 1987; 13(3):134-8. PubMed ID: 3622557
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC.
Holland ME; Bugaj J; Heineman WR; Deutsch E
Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091
[TBL] [Abstract][Full Text] [Related]
14. The effect of DMSO treatment on the performance of [99mTc]HEDP.
Bugaj JE; Esser PD; Tofe AJ; Borgia AT; Fawwaz RA
Int J Nucl Med Biol; 1984; 11(2):109-11. PubMed ID: 6434460
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina C; Sepúlveda-Méndez J
Arch Med Res; 1996; 27(4):481-3. PubMed ID: 8987181
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-propylene amine oxime (99mTc-PnAO); a potential brain radiopharmaceutical.
Volkert WA; Hoffman TJ; Seger RM; Troutner DE; Holmes RA
Eur J Nucl Med; 1984; 9(11):511-6. PubMed ID: 6394334
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Tc-nitrido group on the behaviour of 99mTc-radiopharmaceuticals.
Baldas J; Bonnyman J
Int J Appl Radiat Isot; 1985 Dec; 36(12):919-23. PubMed ID: 3936786
[TBL] [Abstract][Full Text] [Related]
18. Complexes of technetium with hydroxycarboxylic acids: gluconic, glucoheptonic, tartaric, and citric.
Russell CD; Speiser AG
J Nucl Med; 1980 Nov; 21(11):1086-90. PubMed ID: 7431109
[TBL] [Abstract][Full Text] [Related]
19. Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitro.
Ballinger JR; Cowan DS; Boxen I; Zhang ZM; Rauth AM
J Nucl Med; 1993 Feb; 34(2):242-5. PubMed ID: 8381475
[TBL] [Abstract][Full Text] [Related]
20. Radiation dose from radiopharmaceuticals contaminated with molybdenum-99.
Shearer DR; Pezzullo JC; Moore MM; Coleman P; Frater SI
J Nucl Med; 1988 May; 29(5):695-700. PubMed ID: 2836569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
